(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are HYLORIS, ULTIMOVACS, and BERGENBIO.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| HYLORIS (HYL.BR) | 7.48 | 30.66% | 2024-08-13 12:20:09 |
| ULTIMOVACS (ULTI.OL) | 3.70 | 8.82% | 2024-08-13 12:44:04 |
| BERGENBIO (BGBIO.OL) | 12.41 | 8.55% | 2024-08-13 12:24:57 |
| KENMARE RESOURCES (KMR.IR) | 3.94 | 7.07% | 2024-08-13 12:22:39 |
| SEQUANA MEDICAL (SEQUA.BR) | 1.08 | 6.97% | 2024-08-13 12:21:19 |
| OCEANTEAM (OTS.OL) | 0.96 | 6.44% | 2024-08-13 12:41:46 |
| DIEGEM KENNEDYCERT (DIEG.BR) | 118.00 | 5.36% | 2024-08-13 12:05:45 |
| ARRIBATEC GROUP (ARR.OL) | 4.20 | 5% | 2024-08-13 12:24:36 |
| EBUSCO HOLDING (EBUS.AS) | 0.88 | 5% | 2024-08-13 12:01:39 |
| LERØY SEAFOOD GP (LSG.OL) | 50.00 | 4.52% | 2024-08-13 12:41:01 |
The three biggest losers today are CELYAD ONCOLOGY, IBA, and TKH GROUP.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| CELYAD ONCOLOGY (CYAD.BR) | 0.23 | -6.81% | 2024-08-13 12:05:25 |
| IBA (IBAB.BR) | 11.24 | -6.46% | 2024-08-13 12:20:11 |
| TKH GROUP (TWEKA.AS) | 36.50 | -5.72% | 2024-08-13 12:04:04 |
| ANTIN INFRA PARTN (ANTIN.PA) | 12.02 | -4.91% | 2024-08-13 12:45:41 |
| POLARIS MEDIA (POL.OL) | 71.00 | -4.05% | 2024-08-13 12:42:19 |
| JINHUI SHIPP TRANS (JIN.OL) | 6.20 | -4.02% | 2024-08-13 12:40:40 |
| ARTMARKET COM (PRC.PA) | 4.54 | -4.02% | 2024-08-13 12:45:51 |
| NYXOAH (NYXH.BR) | 7.54 | -3.83% | 2024-08-13 12:20:52 |
| CABKA (CABKA.AS) | 3.52 | -3.83% | 2024-08-13 12:01:07 |
| BORGESTAD (BOR.OL) | 15.30 | -3.76% | 2024-08-13 12:25:05 |
Winners today
1. HYLORIS (HYL.BR)
30.66% Price Change
BEL 20 ended the session with HYLORIS jumping 30.66% to €7.48 on Tuesday while BEL 20 jumped 0.22% to €4,049.50.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HYLORIS’s stock is considered to be oversold (<=20).
More news about HYLORIS.
2. ULTIMOVACS (ULTI.OL)
8.82% Price Change
Ultimovacs ASA, a biotech company, develops immunotherapies against cancers in Norway. Its lead product candidate is UV1, a peptide-based therapeutic cancer vaccine that induces a specific T cell response against the pan-tumor antigen telomerase. Ultimovacs ASA was incorporated in 2011 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ULTIMOVACS jumping 8.82% to €3.70 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.01% to €1,427.65, after five sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-5.2.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -52.14%.
Volume
Today’s last reported volume for ULTIMOVACS is 580999 which is 38.26% above its average volume of 420204.
More news about ULTIMOVACS.
3. BERGENBIO (BGBIO.OL)
8.55% Price Change
BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory diseases in Norway. The company's lead clinical asset is the Bemcentinib (BGB016), an inhibitor of AXL receptor tyrosine kinase (AXL), which is in phase 1b/2a clinical trial to treat non-small cell lung cancer; and (BGBC008), which is in phase 2 clinical trial to treat second-line non-small cell lung cancer (2L NSCLC). It develops Bemcentinib, which is in preclinical trial to treat acute respiratory distress syndrome; Tilvestamab (BGB149), anti-AXL monoclonal antibody, which in phase 1 clinical trial for the treatment of ovarian cancer; and Mipasetamab Uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. BerGenBio ASA was incorporated in 2007 and is based in Bergen, Norway.
Oslo Børs Benchmark Index_GI ended the session with BERGENBIO jumping 8.55% to €12.41 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.01% to €1,427.65.
Earnings Per Share
As for profitability, BERGENBIO has a trailing twelve months EPS of kr67.
PE Ratio
BERGENBIO has a trailing twelve months price to earnings ratio of 0.19. Meaning, the purchaser of the share is investing kr0.19 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.
More news about BERGENBIO.
4. KENMARE RESOURCES (KMR.IR)
7.07% Price Change
Kenmare Resources plc, together with its subsidiaries, engages in the production and sale of mineral sand products in China, the rest of Asia, Europe, the United States, and internationally. It operates the Moma Titanium Minerals Mine located on the northeast coast of Mozambique. The company's products include ilmenite, rutile, and zircon; monazite; and concentrates, including secondary zircon and mineral sand concentrates. It has a total proved and probable ore reserves of 1,429 million tons. The company was formerly known as Kenmare Oil Exploration plc and changed its name to Kenmare Resources plc in 1987. Kenmare Resources plc was incorporated in 1972 and is headquartered in Dublin, Ireland.
ISEQ All Share ended the session with KENMARE RESOURCES rising 7.07% to €3.94 on Tuesday while ISEQ All Share jumped 0.42% to €9,418.45.
Earnings Per Share
As for profitability, KENMARE RESOURCES has a trailing twelve months EPS of €1.26.
PE Ratio
KENMARE RESOURCES has a trailing twelve months price to earnings ratio of 3.13. Meaning, the purchaser of the share is investing €3.13 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.66%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 11, 2024, the estimated forward annual dividend rate is 0.52 and the estimated forward annual dividend yield is 13.35%.
Volatility
KENMARE RESOURCES’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.41%, a negative 0.44%, and a positive 2.63%.
KENMARE RESOURCES’s highest amplitude of average volatility was 4.58% (last week), 2.69% (last month), and 2.63% (last quarter).
More news about KENMARE RESOURCES.
5. SEQUANA MEDICAL (SEQUA.BR)
6.97% Price Change
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.
BEL 20 ended the session with SEQUANA MEDICAL rising 6.97% to €1.08 on Tuesday, following the last session’s upward trend. BEL 20 jumped 0.22% to €4,049.50, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.22.
Volume
Today’s last reported volume for SEQUANA MEDICAL is 10800 which is 76.46% below its average volume of 45881.
More news about SEQUANA MEDICAL.
6. OCEANTEAM (OTS.OL)
6.44% Price Change
Oceanteam ASA does not have significant operations. Previously, it engaged in a subsea and offshore business. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Baerum, Norway.
Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM rising 6.44% to €0.96 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.01% to €1,427.65.
Earnings Per Share
As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.24.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.79%.
More news about OCEANTEAM.
7. DIEGEM KENNEDYCERT (DIEG.BR)
5.36% Price Change
Immolease Trust NV operates as a subsidiary of KBC Bank NV.
BEL 20 ended the session with DIEGEM KENNEDYCERT rising 5.36% to €118.00 on Tuesday, after five consecutive sessions in a row of losses. BEL 20 jumped 0.22% to €4,049.50, following the last session’s downward trend on what was a somewhat up trend trading session today.
Volatility
DIEGEM KENNEDYCERT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.25%, a negative 1.04%, and a positive 4.54%.
DIEGEM KENNEDYCERT’s highest amplitude of average volatility was 6.25% (last week), 5.82% (last month), and 4.54% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DIEGEM KENNEDYCERT’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for DIEGEM KENNEDYCERT is 10 which is 74.35% below its average volume of 39.
More news about DIEGEM KENNEDYCERT.
8. ARRIBATEC GROUP (ARR.OL)
5% Price Change
Arribatec Group ASA, a software and consulting company, provides digital business solutions in Norway, Europe, the Americas, and internationally. The company offers solutions for businesses, including ERP systems, integrations, consulting, health checks, develops, HR and payroll, financial and project planning, bank solutions, and travel and expenses. Its solutions include QualiWare, a management system that structures and visualizes processes, activities, regulations, and requirements; Unit4 solutions; RamBase, an ERP business solution that gives control over the value chain; Power BI solutions; Hypergene, a business management tool; Adra Suite that integrates with other financial systems; Microsoft 365; CatalystOne; and Pagero that ensures compliance with legal and electronic billing requirements. Arribatec Group ASA was incorporated in 1998 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ARRIBATEC GROUP jumping 5% to €4.20 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.01% to €1,427.65.
Earnings Per Share
As for profitability, ARRIBATEC GROUP has a trailing twelve months EPS of kr-0.37.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.94%.
Volume
Today’s last reported volume for ARRIBATEC GROUP is 73271 which is 34.27% below its average volume of 111484.
Volatility
ARRIBATEC GROUP’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.50%, a negative 0.41%, and a positive 2.68%.
ARRIBATEC GROUP’s highest amplitude of average volatility was 3.83% (last week), 2.97% (last month), and 2.68% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 557M for the twelve trailing months.
Moving Average
ARRIBATEC GROUP’s worth is way under its 50-day moving average of kr5.92 and way above its 200-day moving average of kr3.71.
More news about ARRIBATEC GROUP.
9. EBUSCO HOLDING (EBUS.AS)
5% Price Change
Ebusco Holding N.V., together with its subsidiaries, engages in the development, manufacture, and distribution of zero emission buses and charging systems. It also provides ancillary products and services to electric vehicle ecosystem; and manufactures and supplies energy storage systems and mobile energy containers, as well as repair and maintenance services. The company operates in the Netherlands, Belgium, France, Germany, Norway, Switzerland, and Denmark. Ebusco Holding N.V. was founded in 2010 and is headquartered in Deurne, the Netherlands.
AEX-Index ended the session with EBUSCO HOLDING jumping 5% to €0.88 on Tuesday while AEX-Index rose 0.37% to €888.91.
Earnings Per Share
As for profitability, EBUSCO HOLDING has a trailing twelve months EPS of €-2.4.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.98%.
Moving Average
EBUSCO HOLDING’s value is way under its 50-day moving average of €1.73 and way below its 200-day moving average of €3.54.
Revenue Growth
Year-on-year quarterly revenue growth declined by 8.9%, now sitting on 98.72M for the twelve trailing months.
Yearly Top and Bottom Value
EBUSCO HOLDING’s stock is valued at €0.88 at 22:40 EST, way under its 52-week high of €8.15 and way higher than its 52-week low of €0.77.
More news about EBUSCO HOLDING.
10. LERØY SEAFOOD GP (LSG.OL)
4.52% Price Change
Lerøy Seafood Group ASA produces, processes, markets, sells, and distributes seafood products worldwide. It operates in three segments: Wildcatch; Farming; and Value-Added Processing, Sales and Distribution. The company offers smoked and gravad salmon, and trout products; farmed and wild catch whole fishes; fillets and portions; ready-to-eat and ready-to-cook products; fish blocks and cubes; breaded products; pre-fried fish burgers and patties; crustaceans and molluscs; seaweeds; and other products. Lerøy Seafood Group ASA markets its products primarily under the Norway Seafoods, Arctic Supreme, Fjord trout, Aurora Salmon, Fossen, Sea Eagle, Lerøy, and M?r brands to shops, restaurants, canteens, and hotels. The company was founded in 1899 and is headquartered in Bergen, Norway. Lerøy Seafood Group ASA is a subsidiary of Austevoll Seafood ASA.
Oslo Børs Benchmark Index_GI ended the session with LERØY SEAFOOD GP rising 4.52% to €50.00 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.01% to €1,427.65, after five sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, LERØY SEAFOOD GP has a trailing twelve months EPS of kr-0.37.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.39%.
More news about LERØY SEAFOOD GP.
Losers Today
1. CELYAD ONCOLOGY (CYAD.BR)
-6.81% Price Change
Celyad Oncology SA, a biopharmaceutical company, focuses on the research and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. The company is developing shRNA non-gene-edited technology, which allows for the development of allogenic CAR T-cells through the modulation of genes encoding the TCR without the need for gene editing; multi-specific CAR T-cell platform that focuses on the NKG2D receptor; NKG2D-based CAR T-cell therapies; and B7-H6 targeting CAT T-cell therapies. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery/PerkinElmer for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.
BEL 20 ended the session with CELYAD ONCOLOGY dropping 6.81% to €0.23 on Tuesday while BEL 20 rose 0.22% to €4,049.50.
Earnings Per Share
As for profitability, CELYAD ONCOLOGY has a trailing twelve months EPS of €-1.36.
Volatility
CELYAD ONCOLOGY’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.24%, a negative 0.40%, and a positive 3.01%.
CELYAD ONCOLOGY’s highest amplitude of average volatility was 4.91% (last week), 2.51% (last month), and 3.01% (last quarter).
Volume
Today’s last reported volume for CELYAD ONCOLOGY is 13503 which is 1.03% above its average volume of 13365.
More news about CELYAD ONCOLOGY.
2. IBA (IBAB.BR)
-6.46% Price Change
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
BEL 20 ended the session with IBA falling 6.46% to €11.24 on Tuesday, after three sequential sessions in a row of losses. BEL 20 rose 0.22% to €4,049.50, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, IBA has a trailing twelve months EPS of €-0.31.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.2%.
More news about IBA.
3. TKH GROUP (TWEKA.AS)
-5.72% Price Change
TKH Group N.V. develops and delivers smart vision, smart manufacturing, and smart connectivity systems in the Netherlands, Europe, Asia, North America, and internationally. The Smart Vision Systems segment provides 2D and 3D machine vision used to enhance quality inspection, operation, and object monitoring; and security vision technologies that enable customers to manage and control the urban environment, as well as enhances efficiency, safety, and security in various markets, such as infrastructure, parking, and building security. This segment serves various industries, such as consumer electronics, factory automation, logistics, wood, intelligent transport systems, medical, and life sciences. The Smart Manufacturing Systems segment offers systems engineering and assembly, control and analysis software, and connectivity and vision technologies to car and truck tire production, and factory automation industries; and care solutions, including medicine distribution machines. The Smart Connectivity Systems segment develops connectivity systems for on-shore and off-shore energy distribution; fiber optic connectivity systems for data and communication networks; and specialized cable systems for various industrial automation applications, such as the industrial, marine and offshore, and medical sectors, as well as provides contactless energy and data distribution comprising hardware components and intelligent software for airfield ground lighting systems. The company was formerly known as NV Twentsche Kabel Holding and changed its name to TKH Group N.V. in 2005. TKH Group N.V. was incorporated in 1980 and is based in Haaksbergen, the Netherlands.
AEX-Index ended the session with TKH GROUP dropping 5.72% to €36.50 on Tuesday, following the last session’s upward trend. AEX-Index jumped 0.37% to €888.91, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, TKH GROUP has a trailing twelve months EPS of €4.07.
PE Ratio
TKH GROUP has a trailing twelve months price to earnings ratio of 8.97. Meaning, the purchaser of the share is investing €8.97 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.43%.
Volume
Today’s last reported volume for TKH GROUP is 217242 which is 264.01% above its average volume of 59679.
Moving Average
TKH GROUP’s value is way under its 50-day moving average of €41.30 and under its 200-day moving average of €38.55.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TKH GROUP’s stock is considered to be oversold (<=20).
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 9, 2024, the estimated forward annual dividend rate is 1.7 and the estimated forward annual dividend yield is 3.87%.
More news about TKH GROUP.
4. ANTIN INFRA PARTN (ANTIN.PA)
-4.91% Price Change
Antin Infrastructure Partners SAS is a private equity firm specializing in infrastructure investments. The firm does not invest in projects which involve technological or commercial risk associated with developing a clientele in a competitive market or invest alongside partners which could represent counterparty risk. It seeks to invest in main infrastructure sectors including transportation, energy, digital, social infrastructure, environment, and telecommunication. The firm focuses on toll roads, tunnels, highways, tramways, bridges; airports; ports; urban rail, bus lines; car parks in transport; Motorway Service Areas (MSAs); gas storage; LNG terminals; transmission (pipelines, high-voltage electricity transmission); distribution; buildings and public works, generation (non-merchant); water infrastructure (pipelines & sewage units); waste management in energy and environment; and GSM towers; ADSL networks; broadcast networks; cable networks; and satellites in Telecommunication. It typically to invests in non-listed companies based in continental Europe including United Kingdom and North America. It seeks to invest between €600 million ($643.62 million) to €1000 million ($1072.70 million) in flagship, between €50 million ($53.63 million) to €300 million ($321.81 million) in mid cap, between €20 million ($21.45 million) to €200 million ($214.54 million) in nextgen. The firm may take minority or majority stake allowing representation to the board of directors. It essentially invests in equity and may invest alone or co-invest through a consortium. Antin Infrastructure Partners S.A.S. was founded in 2007 and is based in Paris, France with additional offices in London, United Kingdom, Luxembourg, Luxembourg, Singapore, Singapore, Seoul, South Korea and New York, New York.
CAC 40 ended the session with ANTIN INFRA PARTN sliding 4.91% to €12.02 on Tuesday, following the last session’s downward trend. CAC 40 rose 0.35% to €7,275.87, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, ANTIN INFRA PARTN has a trailing twelve months EPS of €0.42.
PE Ratio
ANTIN INFRA PARTN has a trailing twelve months price to earnings ratio of 28.62. Meaning, the purchaser of the share is investing €28.62 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.4%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 17, 2024, the estimated forward annual dividend rate is 0.71 and the estimated forward annual dividend yield is 5.77%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ANTIN INFRA PARTN’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for ANTIN INFRA PARTN is 15835 which is 44.62% below its average volume of 28598.
More news about ANTIN INFRA PARTN.
5. POLARIS MEDIA (POL.OL)
-4.05% Price Change
Polaris Media ASA operates as a media house and printing company in Norway and Sweden. The company provides digital advertising services. It also prints group and external newspapers, including editorial supplements, advertising supplements and newspapers, civil prints, and other magazines/supplements. In addition, the company distributes newspapers, as well as parcels, mails, and food deliveries. The company was founded in 2008 and is headquartered in Trondheim, Norway.
Oslo Børs Benchmark Index_GI ended the session with POLARIS MEDIA falling 4.05% to €71.00 on Tuesday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.01% to €1,427.65, after five sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, POLARIS MEDIA has a trailing twelve months EPS of kr-0.46.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.63%.
Yearly Top and Bottom Value
POLARIS MEDIA’s stock is valued at kr71.00 at 22:40 EST, way under its 52-week high of kr88.00 and way above its 52-week low of kr48.20.
Volume
Today’s last reported volume for POLARIS MEDIA is 88 which is 99.71% below its average volume of 31359.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.4%, now sitting on 3.62B for the twelve trailing months.
Volatility
POLARIS MEDIA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.41%, a negative 0.10%, and a positive 2.13%.
POLARIS MEDIA’s highest amplitude of average volatility was 2.76% (last week), 2.05% (last month), and 2.13% (last quarter).
More news about POLARIS MEDIA.
6. JINHUI SHIPP TRANS (JIN.OL)
-4.02% Price Change
Jinhui Shipping and Transportation Limited, an investment holding company, engages in ship chartering and owning activities internationally. The company engages in money lending; property investment activities; and management and shipping agent services. It also owns a fleet of twenty three grabs fitted supramaxes and one chartered-in-panamax with carrying capacity of approximately 1,415,930 metric tons. The company was founded in 1987 and is based in Hong Kong, Hong Kong. Jinhui Shipping and Transportation Limited operates as a subsidiary of Jinhui Holdings Company Limited.
Oslo Børs Benchmark Index_GI ended the session with JINHUI SHIPP TRANS dropping 4.02% to €6.20 on Tuesday, after four consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.01% to €1,427.65, after five sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, JINHUI SHIPP TRANS has a trailing twelve months EPS of kr-3.95.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.64%.
More news about JINHUI SHIPP TRANS.
7. ARTMARKET COM (PRC.PA)
-4.02% Price Change
Artmarket.com provides art market information in France. It also operates as a marketplace to buy or sell artworks; and engages in sale of fine arts and NFT, and design auction services activities. The company was formerly known as Artprice.com and changed its name to Artmarket.com. Artmarket.com was incorporated in 1997 and is based in Saint-Romain-au-Mont-d'Or, France.
CAC 40 ended the session with ARTMARKET COM sliding 4.02% to €4.54 on Tuesday, following the last session’s upward trend. CAC 40 jumped 0.35% to €7,275.87, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, ARTMARKET COM has a trailing twelve months EPS of €0.13.
PE Ratio
ARTMARKET COM has a trailing twelve months price to earnings ratio of 34.92. Meaning, the purchaser of the share is investing €34.92 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.71%.
More news about ARTMARKET COM.
8. NYXOAH (NYXH.BR)
-3.83% Price Change
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
BEL 20 ended the session with NYXOAH falling 3.83% to €7.54 on Tuesday, after two sequential sessions in a row of gains. BEL 20 rose 0.22% to €4,049.50, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.48.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.94%.
Moving Average
NYXOAH’s value is below its 50-day moving average of €7.83 and under its 200-day moving average of €8.25.
More news about NYXOAH.
9. CABKA (CABKA.AS)
-3.83% Price Change
Cabka N.V. manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally. The company also offers services, including customized solutions; track and trace; and life cycle and carbon footprint analysis. It sells its recycled plastic products to the agriculture, food and beverage, retail, automotive, chemical, pharmaceutical, and pooling industries. The company was incorporated in 1994 and is headquartered in Berlin, Germany.
AEX-Index ended the session with CABKA sliding 3.83% to €3.52 on Tuesday while AEX-Index jumped 0.37% to €888.91.
Earnings Per Share
As for profitability, CABKA has a trailing twelve months EPS of €-0.06.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.15%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 8, 2024, the estimated forward annual dividend rate is 0.15 and the estimated forward annual dividend yield is 4.12%.
Yearly Top and Bottom Value
CABKA’s stock is valued at €3.52 at 22:40 EST, under its 52-week low of €3.54.
Moving Average
CABKA’s worth is way below its 50-day moving average of €4.08 and way below its 200-day moving average of €5.40.
Volatility
CABKA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.27%, a negative 0.03%, and a positive 2.04%.
CABKA’s highest amplitude of average volatility was 2.50% (last week), 2.03% (last month), and 2.04% (last quarter).
More news about CABKA.
10. BORGESTAD (BOR.OL)
-3.76% Price Change
Borgestad ASA develops, manufactures, distributes, delivers, and installs refractory products in Norway. The company also develops and manages real estate properties. It operates Agora Bytom, a shopping center and a rental area, as well as a parking garage with parking spaces in Poland. Borgestad ASA was founded in 1904 and is headquartered in Skien, Norway.
Oslo Børs Benchmark Index_GI ended the session with BORGESTAD sliding 3.76% to €15.30 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.01% to €1,427.65, after five successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, BORGESTAD has a trailing twelve months EPS of kr-0.96.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.11%.
Volume
Today’s last reported volume for BORGESTAD is 1726 which is 96.16% below its average volume of 45025.
More news about BORGESTAD.
Stay up to date with our winners and losers daily report
